Overview

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This is an one-year open-label study to determine treatment efficacy and feasibility of a trial that uses open-label interventions in ADPKD patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Southern California
Treatments:
Citric Acid
Pravastatin
Sodium Citrate